39W: (2S,3aS,10Z,11aS,12aR)-2-({8-fluoro-7-methoxy-2-[4-(propan-2-yl)-1,3-thiazol-2-yl]quinolin-4-yl}oxy)-5-methyl-N-[(1-methylcyclopropyl)sulfonyl]-4,14-dioxo-1,2,3,3a,4,5,6,7,8,9,11a,12,13,14-tetradecahydro-12aH-cyclopropa[m]pyrrolo[1,2-c][1,3,6]triazacyclotetradecine-12a-carboxamide
39W is a Ligand Of Interest in 4U01 designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
| 4U01_39W_C_301 | 88% | 7% | 0.072 | 0.954 | 1.57 | 3.04 | 7 | 20 | 3 | 0 | 100% | 1 |
| 4U01_39W_D_301 | 88% | 5% | 0.08 | 0.96 | 1.74 | 3.36 | 7 | 26 | 8 | 0 | 100% | 1 |
| 4U01_39W_B_301 | 86% | 7% | 0.076 | 0.948 | 1.7 | 3 | 7 | 25 | 0 | 0 | 100% | 1 |
| 4U01_39W_F_301 | 85% | 8% | 0.082 | 0.952 | 1.64 | 2.84 | 7 | 21 | 2 | 0 | 100% | 1 |
| 4U01_39W_H_301 | 81% | 7% | 0.082 | 0.938 | 1.67 | 2.97 | 8 | 22 | 5 | 0 | 100% | 1 |
| 4U01_39W_E_301 | 81% | 9% | 0.083 | 0.937 | 1.6 | 2.74 | 6 | 25 | 3 | 0 | 100% | 1 |
| 4U01_39W_A_301 | 80% | 7% | 0.096 | 0.948 | 1.69 | 3.02 | 7 | 19 | 6 | 0 | 100% | 1 |
| 4U01_39W_G_301 | 75% | 8% | 0.096 | 0.932 | 1.61 | 2.95 | 8 | 22 | 0 | 0 | 100% | 1 |
| 4U01_39W_J_301 | 49% | 9% | 0.108 | 0.853 | 1.65 | 2.71 | 8 | 21 | 0 | 0 | 100% | 1 |